(1888PressRelease)
November 10, 2007 - New theories, upon which NextGen Bioscience base their work, have shown that treatments targeted at cancer stem cells could prove to be far superior to traditional treatments used today. NextGen theories apparently state that tumors arise from cancer stem cells which, like adult stem cells, have the ability to self renew and differentiate into multiple cell types, thereby causing the disease to relapse and give rise to new tumours in patients.
NextGen’s business model concentrates on recent discoveries supporting that most tumours are derived from of a single cancer-initiating cell having stem cell properties, a cancer stem cell.
NextGen are said to believe that problems with traditional treatment lie in the fact the efficacy of these treatments are, only really in the early stages of testing, and are simply by the amount of tumour mass they kill off. As cancer stem cells form a very small proportion of the tumour, NextGen feel that this may not necessarily be effective, as traditional therapies leave behind stem cells which may cause a relapse of the disease. NextGen’s aim is to develop targeted, specific therapies which could offer hope to sufferers of the killer disease.
